Refractory anti-synthetase syndrome treated with rituximab

Rheumatology (Oxford). 2010 May;49(5):1013. doi: 10.1093/rheumatology/kep438. Epub 2009 Dec 23.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / adverse effects
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Creatine Kinase / metabolism
  • Humans
  • Ligases / metabolism
  • Lung Diseases, Interstitial / drug therapy*
  • Male
  • Rituximab
  • Syndrome
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
  • Creatine Kinase
  • Ligases